GlaxoSmithKline
GSK
#288
Rank
C$96.64 B
Marketcap
$46.95
Share price
-2.00%
Change (1 day)
-0.60%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $4.72

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $4.93. In 2022 the company made an earnings per share (EPS) of $11.95 an increase over its 2021 EPS that were of $4.22.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.72-60.49%
2022$11.95183.39%
2021$4.22-17.83%
2020$5.1321.82%
2019$4.2123.91%
2018$3.40141.48%
2017$1.4164.6%
2016$0.86-90.64%
2015$9.14178.14%
2014$3.29-48.16%
2013$6.3422.63%
2012$5.17-11.32%
2011$5.83230.25%
2010$1.76-70.98%
2009$6.086.76%
2008$5.70-15.14%
2007$6.717.82%
2006$6.2319.61%
2005$5.2018.56%
2004$4.390.36%
2003$4.3750.39%
2002$2.9131.13%
2001$2.22-25.43%
2000$2.9731.58%
1999$2.261.05%
1998$2.24-0.98%
1997$2.26-10.07%
1996$2.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.80-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.62-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.57-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.27 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.48-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$2.82-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.23-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA